Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07184983

RS-tDCS for Cannabis Use Disorder: The C.A.R.E.S. Initiative

Telehealth-Delivered tDCS for Cannabis Addiction Recovery: The C.A.R.E.S. (Cannabis Addiction Recovery Enhancement Stimulation) Initiative

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
46 (estimated)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
22 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this sham-controlled pilot randomized controlled trial (RCT) is to evaluate the feasibility, safety, and preliminary efficacy of a one-month intervention consisting of 20 home-based active or sham RS-tDCS sessions paired with audio track guided mindfulness meditation practice in otherwise healthy adults seeking to reduce cannabis use in the context of cannabis use disorder (CUD).

Conditions

Interventions

TypeNameDescription
DEVICEActive Transcranial Direct Current Stimulation (tDCS)tDCS is a noninvasive brain stimulation device that modulates brain activity by delivering low-intensity electrical current (2.0 mA) through scalp sponge electrodes. Device is programmed to ramp up to 2.0 mA (for 30 seconds), provide constant current throughout the session (19 minutes), and then ramp down (for 30 seconds) at the end.
DEVICESham Transcranial Direct Current Stimulation (tDCS)tDCS is a noninvasive brain stimulation device that modulates brain activity by delivering low-intensity electrical current (2.0 mA) through scalp sponge electrodes. Device is programmed to ramp up to 2.0 mA (for 30 seconds) followed by a ramp down (30 seconds), with no current delivery for 18 minutes, and then ramp up (for 30 seconds) and down (for 30 seconds) at the end.
BEHAVIORALMindfulness meditationParticipants will follow an audio track for guided mindfulness during the stimulation.

Timeline

Start date
2025-11-12
Primary completion
2026-10-01
Completion
2027-11-01
First posted
2025-09-22
Last updated
2025-11-13

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT07184983. Inclusion in this directory is not an endorsement.